B Lynne Parshall insider trades
Open-market stock purchases and sales by B Lynne Parshall, Director at Cytokinetics Inc, from SEC Form 4 filings since Jan 4, 2010.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 1, 2026 | CYTK Cytokinetics Inc | Sold | $357K |
| Jun 24, 2026 | FHTX Foghorn Therapeutics Inc | Bought (not open market) | $114K |
| Jun 1, 2026 | CYTK Cytokinetics Inc | Sold | $370K |
| May 27, 2026 | CYTK Cytokinetics Inc | Bought (not open market) | — |
| May 27, 2026 | CYTK Cytokinetics Inc | Bought (not open market) | — |
| Apr 15, 2026 | IONS Ionis Pharmaceuticals Inc | Sold | $340K |
| Apr 15, 2026 | IONS Ionis Pharmaceuticals Inc | Sold | $41.1K |
| Mar 2, 2026 | CYTK Cytokinetics Inc | Sold | $306K |
| Feb 11, 2026 | IONS Ionis Pharmaceuticals Inc | Sold | $414K |
| Nov 19, 2025 | CYTK Cytokinetics Inc | Sold | $324K |
| Oct 15, 2025 | IONS Ionis Pharmaceuticals Inc | Sold | $359K |
Companies traded
- CYTK Cytokinetics Inc: 24 sales, last Sep 1, 2026
- FHTX Foghorn Therapeutics Inc: other filings, last Jun 24, 2026
- IONS Ionis Pharmaceuticals Inc: 35 sales, last Apr 15, 2026
- AKCA Akcea Therapeutics, Inc: other filings, last Oct 12, 2020
- ISIS Isis Pharmaceuticals Inc: 63 sales, last Nov 9, 2015
- RGLS Regulus Therapeutics Inc: 1 buy, last Oct 10, 2012